innovation, ecology, genetics & genomics
GM Paper Flagged by Politician Retracted
GM Paper Flagged by Politician Retracted
Kerry Grens | Jan 18, 2016
One of three suspect publications from a group of scientists in Italy is pulled for plagiarism while an investigation is ongoing.
Who Owns CRISPR, Cont’d
Who Owns CRISPR, Cont’d
Jef Akst | Jan 14, 2016
The US Patent and Trademark Office declares a patent “interference” and will seek to determine who has rights to the gene-editing technology.
Thermo Fisher to Acquire Affymetrix
Thermo Fisher to Acquire Affymetrix
Tracy Vence | Jan 11, 2016
The boards of both companies have agreed to a $1.3 billion deal, which is subject to Affymetrix shareholder approval.
Disease-Linked Genes Questioned
Disease-Linked Genes Questioned
Jef Akst | Jan 6, 2016
Many patients with genetic variations linked to cardiac disorders do not exhibit any symptoms, raising concerns about the validity of incidental findings of genetic tests.
TS Picks: CRISPR Patent Edition
TS Picks: CRISPR Patent Edition
Kerry Grens | Jan 5, 2016
A challenge to the first CRISPR patent just got teeth.
CRISPR Improves Disease in Adult Mice
CRISPR Improves Disease in Adult Mice
Kerry Grens | Jan 4, 2016
Three groups of researchers used the gene-editing method to restore a protein deficient in Duchenne muscular dystrophy.
Reveling in the Revealed
Reveling in the Revealed
Kelly Rae Chi | Jan 1, 2016
A growing toolbox for surveying the activity of entire genomes
Contributors
Contributors
Karen Zusi | Jan 1, 2016
Meet some of the people featured in the January 2016 issue of The Scientist.
All Together Now
All Together Now
Mary Beth Aberlin | Jan 1, 2016
Understanding the biological roots of cooperation might help resolve some of the biggest scientific challenges we face.
Speaking of Science
Speaking of Science
The Scientist Staff | Jan 1, 2016
January 2016's selection of notable quotes